ORKA-002

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisNCT07474792ORKAPhase 2Active not recruiting2027-10Estimated
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaNCT07783542ORKAPhase 2Recruiting2028-10Estimated
An Open-label Study With Maintenance Dosing of ORKA-002 in Participants With Moderate-to-Severe Plaque PsoriasisNCT07933783ORKAPhase 2Enrolling by invitation2029-07-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.